Methicillin-Resistant Staphylococcus aureus

Methicillin-Resistant Staphylococcus aureus

Methicillin-Resistant Staphylococcus aureus

On this page

MRSA Overview - Superbug Spotlight

  • Definition: S. aureus resistant to methicillin, oxacillin & most β-lactams.
  • Mechanism: mecA gene encodes PBP2a, conferring broad β-lactam resistance.
  • Types & Features:
    • HA-MRSA (Healthcare-Associated): Nosocomial, often multi-drug resistant (MDR), causes severe invasive disease.
    • CA-MRSA (Community-Associated): Affects community, skin/soft tissue infections (SSTIs) common, frequently PVL toxin positive.
  • Significance & Epidemiology: Critical "superbug"; global threat causing difficult infections, ↑morbidity, ↑mortality, ↑healthcare burden. Common nosocomial & emerging community pathogen.

⭐ CA-MRSA: often more virulent (PVL), yet susceptible to more non-β-lactams (clindamycin, TMP-SMX) vs HA-MRSA.

Resistance Mechanism - Genetic Armor

  • mecA Gene: Cornerstone of resistance.
    • Encodes Penicillin-Binding Protein 2a (PBP2a).
    • PBP2a: Low affinity for β-lactams (e.g., methicillin, oxacillin, nafcillin, cephalosporins).
    • Allows continued cell wall synthesis in antibiotic presence.
  • SCCmec (Staphylococcal Cassette Chromosome mec):
    • Mobile genetic element carrying mecA.
    • Facilitates horizontal gene transfer of resistance.
    • Multiple types (e.g., I, II, III, IV, V) exist, influencing epidemiology.

⭐ SCCmec types II & III are often linked to hospital-acquired MRSA (HA-MRSA), while type IV is common in community-acquired MRSA (CA-MRSA). MRSA resistance mechanisms diagram

Clinical Manifestations - MRSA's Attack Plan

  • Skin & Soft Tissue Infections (SSTIs): Most frequent.
    • Localized, pus-filled: Abscesses (hallmark), furuncles, carbuncles.
    • Spreading infections: Cellulitis, impetigo, erysipelas.
    • Complicated: Surgical site infections (SSIs), necrotizing fasciitis (rare but severe).
  • Invasive & Systemic Infections: High morbidity/mortality.
    • Bacteremia/Sepsis: Can rapidly progress to septic shock.
    • Pneumonia:
      • CA-MRSA: Severe, necrotizing pneumonia (often post-influenza), PVL toxin associated.
      • HA-MRSA: Common cause of Ventilator-Associated Pneumonia (VAP).
    • Infective Endocarditis (IE): Especially in IV drug users (IVDU) & patients with prosthetic valves.
    • Musculoskeletal: Osteomyelitis, septic arthritis.
    • Device-related: Catheter-associated UTIs. MRSA Necrotizing Pneumonia Pathway

⭐ CA-MRSA is often associated with Panton-Valentine Leukocidin (PVL) toxin, enhancing virulence and causing tissue necrosis in severe skin infections and necrotizing pneumonia.

Diagnosis & Management - Unmask & Combat

  • Diagnosis:
    • Screening: Cefoxitin disc diffusion (30µg) is preferred; zone ≤21mm for S. aureus indicates resistance.
    • Gold Standard: PCR for mecA gene (detects PBP2a directly).
    • Rapid Tests: PBP2a latex agglutination for quick PBP2a detection; chromogenic agars for direct MRSA identification.
  • Management Approach:
  • Key Antimicrobials:
    • Vancomycin: Primary for HA-MRSA & severe infections.
    • Linezolid: Good oral bioavailability; for VRE, MRSA.
    • Daptomycin: Bactericidal; avoid in pneumonia (surfactant inactivation).
    • Ceftaroline: Anti-MRSA cephalosporin.
  • Decolonization: Nasal mupirocin for carriers to reduce transmission.

⭐ The mecA gene confers resistance by encoding Penicillin-Binding Protein 2a (PBP2a), which has low affinity for β-lactam antibiotics.

Prevention & Control - Fortifying Defenses

  • Hand Hygiene: Cornerstone! Alcohol-based hand rubs (ABHR) or soap & water.
  • Contact Precautions: Gown, gloves for patient/environment contact. Patient isolation/cohorting.
  • Environmental Disinfection: Regular cleaning of shared equipment & high-touch surfaces.
  • Screening: Active surveillance cultures (e.g., nasal swabs) for high-risk admissions.
  • Decolonization: Intranasal mupirocin, topical chlorhexidine baths for identified carriers.
  • Antimicrobial Stewardship: Optimize antibiotic selection, dose, duration.

⭐ Strict adherence to hand hygiene and contact precautions is paramount in preventing MRSA transmission.

High‑Yield Points - ⚡ Biggest Takeaways

  • MRSA resistance is primarily due to the mecA gene, which encodes an altered penicillin-binding protein, PBP2a.
  • The mecA gene is located on a mobile genetic element called Staphylococcal Cassette Chromosome mec (SCCmec).
  • Vancomycin is the drug of choice; alternatives for resistant strains include Linezolid and Daptomycin.
  • Cefoxitin disc diffusion test is the recommended phenotypic method for MRSA screening.
  • Confirmation involves detection of the mecA gene (e.g., PCR) or PBP2a (e.g., latex agglutination).
  • Community-acquired MRSA (CA-MRSA) often carries the Panton-Valentine Leukocidin (PVL) toxin and may be susceptible to non-β-lactams like clindamycin or TMP-SMX.
  • MRSA is a major cause of nosocomial infections, including pneumonia and surgical site infections.

Practice Questions: Methicillin-Resistant Staphylococcus aureus

Test your understanding with these related questions

A patient develops an infection of methicillin resistant Staphylococcus aureus. All of the following can be used to treat this infection except

1 of 5

Flashcards: Methicillin-Resistant Staphylococcus aureus

1/8

Tube and Agar dilution method are _____ methods to test antibiotic sensitivity.

TAP TO REVEAL ANSWER

Tube and Agar dilution method are _____ methods to test antibiotic sensitivity.

dilution

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial